317 related articles for article (PubMed ID: 15470721)
1. Cyclosilicate nanocomposite: a novel resorbable bioactive tissue engineering scaffold for BMP and bone-marrow cell delivery.
El-Ghannam A; Ning CQ; Mehta J
J Biomed Mater Res A; 2004 Dec; 71(3):377-90. PubMed ID: 15470721
[TBL] [Abstract][Full Text] [Related]
2. Bone engineering of the rabbit ulna.
El-Ghannam A; Cunningham L; Pienkowski D; Hart A
J Oral Maxillofac Surg; 2007 Aug; 65(8):1495-502. PubMed ID: 17656274
[TBL] [Abstract][Full Text] [Related]
3. Advanced bioceramic composite for bone tissue engineering: design principles and structure-bioactivity relationship.
El-Ghannam AR
J Biomed Mater Res A; 2004 Jun; 69(3):490-501. PubMed ID: 15127396
[TBL] [Abstract][Full Text] [Related]
4. Improvement of porous beta-TCP scaffolds with rhBMP-2 chitosan carrier film for bone tissue application.
Abarrategi A; Moreno-Vicente C; Ramos V; Aranaz I; Sanz Casado JV; López-Lacomba JL
Tissue Eng Part A; 2008 Aug; 14(8):1305-19. PubMed ID: 18491953
[TBL] [Abstract][Full Text] [Related]
5. Effect of bioactive ceramic dissolution on the mechanism of bone mineralization and guided tissue growth in vitro.
El-Ghannam A; Ning CQ
J Biomed Mater Res A; 2006 Feb; 76(2):386-97. PubMed ID: 16270343
[TBL] [Abstract][Full Text] [Related]
6. The interactions between rat-adipose-derived stromal cells, recombinant human bone morphogenetic protein-2, and beta-tricalcium phosphate play an important role in bone tissue engineering.
E LL; Xu LL; Wu X; Wang DS; Lv Y; Wang JZ; Liu HC
Tissue Eng Part A; 2010 Sep; 16(9):2927-40. PubMed ID: 20486786
[TBL] [Abstract][Full Text] [Related]
7. Mixing conditions for cell scaffolds affect the bone formation induced by bone engineering with human bone marrow stromal cells, beta-tricalcium phosphate granules, and rhBMP-2.
Uchida M; Agata H; Sagara H; Shinohara Y; Kagami H; Asahina I
J Biomed Mater Res A; 2009 Oct; 91(1):84-91. PubMed ID: 18767063
[TBL] [Abstract][Full Text] [Related]
8. Dissolution kinetics of a Si-rich nanocomposite and its effect on osteoblast gene expression.
Gupta G; Kirakodu S; El-Ghannam A
J Biomed Mater Res A; 2007 Feb; 80(2):486-96. PubMed ID: 17019725
[TBL] [Abstract][Full Text] [Related]
9. Electrospun silk-BMP-2 scaffolds for bone tissue engineering.
Li C; Vepari C; Jin HJ; Kim HJ; Kaplan DL
Biomaterials; 2006 Jun; 27(16):3115-24. PubMed ID: 16458961
[TBL] [Abstract][Full Text] [Related]
10. Mechanical properties and cytotoxicity of a resorbable bioactive implant prepared by rapid prototyping technique.
El-Ghannam A; Hart A; White D; Cunningham L
J Biomed Mater Res A; 2013 Oct; 101(10):2851-61. PubMed ID: 23504981
[TBL] [Abstract][Full Text] [Related]
11. Segmental bone regeneration using an rhBMP-2-loaded gelatin/nanohydroxyapatite/fibrin scaffold in a rabbit model.
Liu Y; Lu Y; Tian X; Cui G; Zhao Y; Yang Q; Yu S; Xing G; Zhang B
Biomaterials; 2009 Oct; 30(31):6276-85. PubMed ID: 19683811
[TBL] [Abstract][Full Text] [Related]
12. Ectopic osteoinduction and early degradation of recombinant human bone morphogenetic protein-2-loaded porous beta-tricalcium phosphate in mice.
Liang G; Yang Y; Oh S; Ong JL; Zheng C; Ran J; Yin G; Zhou D
Biomaterials; 2005 Jul; 26(20):4265-71. PubMed ID: 15683650
[TBL] [Abstract][Full Text] [Related]
13. Targeted delivery system for juxtacrine signaling growth factor based on rhBMP-2-mediated carrier-protein conjugation.
Liu HW; Chen CH; Tsai CL; Hsiue GH
Bone; 2006 Oct; 39(4):825-36. PubMed ID: 16782421
[TBL] [Abstract][Full Text] [Related]
14. Exogenous recombinant human BMP-2 has little initial effects on human osteoblastic cells cultured on collagen type I coated/noncoated hydroxyapatite ceramic granules.
Turhani D; Weissenböck M; Stein E; Wanschitz F; Ewers R
J Oral Maxillofac Surg; 2007 Mar; 65(3):485-93. PubMed ID: 17307597
[TBL] [Abstract][Full Text] [Related]
15. Porous beta tricalcium phosphate scaffolds used as a BMP-2 delivery system for bone tissue engineering.
Sohier J; Daculsi G; Sourice S; de Groot K; Layrolle P
J Biomed Mater Res A; 2010 Mar; 92(3):1105-14. PubMed ID: 19301273
[TBL] [Abstract][Full Text] [Related]
16. Bony engineering using time-release porous scaffolds to provide sustained growth factor delivery.
Szpalski C; Nguyen PD; Cretiu Vasiliu CE; Chesnoiu-Matei I; Ricci JL; Clark E; Smay JE; Warren SM
J Craniofac Surg; 2012 May; 23(3):638-44. PubMed ID: 22565873
[TBL] [Abstract][Full Text] [Related]
17. Resorbable glass-ceramic phosphate-based scaffolds for bone tissue engineering: synthesis, properties, and in vitro effects on human marrow stromal cells.
Vitale-Brovarone C; Ciapetti G; Leonardi E; Baldini N; Bretcanu O; Verné E; Baino F
J Biomater Appl; 2011 Nov; 26(4):465-89. PubMed ID: 20566654
[TBL] [Abstract][Full Text] [Related]
18. Bone morphogenetic protein-2 enhances bone formation when delivered by a synthetic matrix containing hydroxyapatite/tricalciumphosphate.
Jung RE; Weber FE; Thoma DS; Ehrbar M; Cochran DL; Hämmerle CH
Clin Oral Implants Res; 2008 Feb; 19(2):188-95. PubMed ID: 18067602
[TBL] [Abstract][Full Text] [Related]
19. Reconstruction of calvarial defect of rabbits using porous calcium silicate bioactive ceramics.
Xu S; Lin K; Wang Z; Chang J; Wang L; Lu J; Ning C
Biomaterials; 2008 Jun; 29(17):2588-96. PubMed ID: 18378303
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(L-lactic-co-glycolic acid) scaffold.
Jeon O; Song SJ; Kang SW; Putnam AJ; Kim BS
Biomaterials; 2007 Jun; 28(17):2763-71. PubMed ID: 17350678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
